Article Details

Respiri to sell wheezo device and technology in the United States after securing FDA approval

Retrieved on: 2021-03-23 00:22:30

Tags for this article:

Click the tags to see associated articles and topics

Respiri to sell wheezo device and technology in the United States after securing FDA approval. View article details on hiswai:

Excerpt

... greenlight from the United States Food and Drug Administration (FDA) to market and sell the technology as a class II medical device in the country.

Article found on: smallcaps.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up